Based on a current laboratory research project, Zarah Dulce
F. Lucas, MD, discusses microRNAs and their potential to
predict brain metastases in patients with triple-negative and
HER2-positive breast cancer.
I often find myself in awe of physicians who travel around the world seeking out the 2 most desirable aspects of medicine-patients in desperate need of medical care and patients with genuinely novel pathology